美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA214956"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
60760-669-90 60760-669 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20250205 N/A ANDA ANDA214956 ST. MARY'S MEDICAL PARK PHARMACY GABAPENTIN 100 mg/1 90 CAPSULE in 1 BOTTLE, PLASTIC (60760-669-90)
50090-7388-0 50090-7388 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20241021 N/A ANDA ANDA214956 A-S Medication Solutions GABAPENTIN 100 mg/1 30 CAPSULE in 1 BOTTLE (50090-7388-0)
50090-7388-1 50090-7388 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20241021 N/A ANDA ANDA214956 A-S Medication Solutions GABAPENTIN 100 mg/1 100 CAPSULE in 1 BOTTLE (50090-7388-1)
50090-7388-2 50090-7388 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20241021 N/A ANDA ANDA214956 A-S Medication Solutions GABAPENTIN 100 mg/1 90 CAPSULE in 1 BOTTLE (50090-7388-2)
50090-7388-3 50090-7388 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20241021 N/A ANDA ANDA214956 A-S Medication Solutions GABAPENTIN 100 mg/1 42 CAPSULE in 1 BOTTLE (50090-7388-3)
76420-870-01 76420-870 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20241105 N/A ANDA ANDA214956 Asclemed USA, Inc. GABAPENTIN 400 mg/1 100 CAPSULE in 1 BOTTLE (76420-870-01)
76420-870-05 76420-870 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20241105 N/A ANDA ANDA214956 Asclemed USA, Inc. GABAPENTIN 400 mg/1 500 CAPSULE in 1 BOTTLE (76420-870-05)
76420-870-12 76420-870 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20241105 N/A ANDA ANDA214956 Asclemed USA, Inc. GABAPENTIN 400 mg/1 120 CAPSULE in 1 BOTTLE (76420-870-12)
76420-870-24 76420-870 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20241105 N/A ANDA ANDA214956 Asclemed USA, Inc. GABAPENTIN 400 mg/1 240 CAPSULE in 1 BOTTLE (76420-870-24)
76420-870-30 76420-870 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20241105 N/A ANDA ANDA214956 Asclemed USA, Inc. GABAPENTIN 400 mg/1 30 CAPSULE in 1 BOTTLE (76420-870-30)
76420-870-60 76420-870 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20241105 N/A ANDA ANDA214956 Asclemed USA, Inc. GABAPENTIN 400 mg/1 60 CAPSULE in 1 BOTTLE (76420-870-60)
76420-870-90 76420-870 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20241105 N/A ANDA ANDA214956 Asclemed USA, Inc. GABAPENTIN 400 mg/1 90 CAPSULE in 1 BOTTLE (76420-870-90)
72865-253-05 72865-253 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20210510 N/A ANDA ANDA214956 XLCare Pharmaceuticals, Inc. GABAPENTIN 300 mg/1 500 CAPSULE in 1 BOTTLE (72865-253-05)
72865-253-18 72865-253 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20210510 N/A ANDA ANDA214956 XLCare Pharmaceuticals, Inc. GABAPENTIN 300 mg/1 180 CAPSULE in 1 BOTTLE (72865-253-18)
72865-253-27 72865-253 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20210510 N/A ANDA ANDA214956 XLCare Pharmaceuticals, Inc. GABAPENTIN 300 mg/1 270 CAPSULE in 1 BOTTLE (72865-253-27)
72865-253-30 72865-253 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20210510 N/A ANDA ANDA214956 XLCare Pharmaceuticals, Inc. GABAPENTIN 300 mg/1 30 CAPSULE in 1 BOTTLE (72865-253-30)
72865-253-60 72865-253 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20210510 N/A ANDA ANDA214956 XLCare Pharmaceuticals, Inc. GABAPENTIN 300 mg/1 60 CAPSULE in 1 BOTTLE (72865-253-60)
72865-253-90 72865-253 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20210510 N/A ANDA ANDA214956 XLCare Pharmaceuticals, Inc. GABAPENTIN 300 mg/1 90 CAPSULE in 1 BOTTLE (72865-253-90)
31722-148-01 31722-148 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20210510 N/A ANDA ANDA214956 Camber Pharmaceuticals, Inc. GABAPENTIN 100 mg/1 100 CAPSULE in 1 BOTTLE (31722-148-01)
31722-148-05 31722-148 HUMAN PRESCRIPTION DRUG GABAPENTIN gabapentin CAPSULE ORAL 20210510 N/A ANDA ANDA214956 Camber Pharmaceuticals, Inc. GABAPENTIN 100 mg/1 500 CAPSULE in 1 BOTTLE (31722-148-05)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2026 Drugfuture->U.S. FDA National Drug Code DataBase